Cortica Snags $80M to Make Autism Care for Children Less Fragmented
Cortica's $80 million raise was co-led by Morgan Health and Nexus NeuroTech Ventures and included participation from Autism Impact Fund.
Centering Cultural Sensitivity in Applied Behavior Analysis
Families of autistic children from underrepresented communities often face the dual challenge of navigating their child’s diagnosis while feeling overlooked by healthcare and therapy systems. How can ABA adapt to meet the needs of an evolving population?
Reducing Clinical and Staff Burnout with AI Automation
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.
Industry Review: ABA Therapy and Why It Is One of the Best Therapy Options for Children With Autism
An opportunity for children to learn and grow in a supportive environment that prioritizes personalized treatment and transparent care
AI Enhancing Multidisciplinary Care in the Autism and IDD Community
Care coordination is complex, but if done effectively, it can positively impact both the learner and the professionals delivering care.
NIH Study: Use of Popular Pain Reliever During Pregnancy Not Linked to Neuro Disorders in Kids
Questions about whether acetaminophen use during pregnancy can lead children to develop neurological problems have sparked scientific inquiry and litigation. Lawsuits are continuing, but a new National Institutes of Health-sponsored study has results that show no causal link between acetaminophen and neurodevelopmental disorders.
This Mom Was Frustrated with the Scarcity of Child Development Specialists — So She Launched a Startup
After experiencing firsthand the shortcomings of existing public and private programs to treat children's developmental delays, Jen Wirt founded a startup called Coral Care. The company, which announced its official launch on Tuesday, brings pediatric developmental specialty care into families’ homes.
Health Executives on Digital Transformation in Healthcare
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.
Forta Health Rakes In $55M to Empower Family Caregivers
Forta Health raised $55 million in Series A funding on Wednesday. The startup offers a platform to help family caregivers quickly access care to manage their loved ones' chronic conditions. Its first area of focus is autism spectrum disorder (ASD).
What The Medical Community Needs to Know to Improve Care for Neurodivergent Patients
As an autistic person with chronic illness, I've sat in my car and cried after doctor's appointments where debilitating symptoms were dismissed as anxiety or communication with staff broke down. That’s why as a healthcare executive, I’m working to change that experience for others like me.
Health Transformation Alliance Teams up With Cognoa for Autism Diagnostic Device
Cognoa's Canvas Dx product is authorized by the Food and Drug Administration and assists healthcare providers in diagnosing autism spectrum disorder for children ages 18 months through 72 months. Members of Health Transformation Alliance can now add Canvas Dx to their benefit plans.
FDA authorizes machine learning software to help diagnose autism
The system, developed by digital health startup Cognoa, uses information from questionnaires and videos to help pediatricians diagnose autism. It received marketing authorization from the FDA on Wednesday.
The Funding Model for Cancer Innovation is Broken — We Can Fix It
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
Under one roof: How to treat autism in children
The need and demand for access to quality, interdisciplinary therapy will only continue to grow. Early intervention, with consistent, qualified care provided under one roof, can generate better outcomes that will help children and their families change what autism means in their lives.
How AI can overcome gender bias in autism diagnosis and treatment
Researchers and advocates have convincingly shown that the wide gap in diagnoses between boys and girls isn’t simply a matter of boys being significantly more likely to be on the autism spectrum.
System1 Biosciences raises $25M in Series A round for neurotherapeutics discovery platform
System1 Biosciences' platform combines stem cell lines from patients with brain diseases with a three-dimensional in vitro system and data analytics.
Cognoa partners with SAP to better support kids’ developmental needs
By teaming up, SAP employees will be able to use Cognoa's app to screen their children for developmental delays in language, behavior and other areas.
Q BioMed strikes an early-stage autism deal with Asdera
Q BioMed and Asdera have signed a licensing deal built around a therapeutic intervention for autism spectrum disorder, which seeks to prevent the loss of speech.